Improved early graft survival in patients receiving aprotinin during orthotopic liver transplantation

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1345-1346

  Molenaar, I Q ^a   Veldman, M ^a   Begliomini, B ^b   Groenland, H N ^c   Januszkiewicz, A ^d   Lindgren, L ^e   Metselaar, H J ^c   Terpstra, O T ^a   Porte, R J ^f  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; PLACEBO;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

ADOLESCENT; ADULT; AGED; APROTININ; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SERINE PROTEINASE INHIBITORS; TIME FACTORS;

EID: 0035084507     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02503-3     Document Type: Article

References (4)

1. Clavien PA: Hepatology 28:281, 1998
2. Porte RJ, Molenaar IQ, Begliomini B, et al: Lancet 355:1303, 2000
3. Hill GE: J Cardiothorac Vasc Anesthesiol 2(suppl 1):21, 1998
4. Oldhafer KJ, Schüttler W, Wiehe B, et al: Transplant Proc 23:2380, 1991